The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Serotonin in Parkinson's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
Olanow, C. W., Goetz, C. G., Kordower, J. H., Stoessl, A. J., Sossi, V., Brin, M. F., Shannon, K. M., Nauert, G. M., Perl, D. P., Godbold, J., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10720 · Cited by 1,307
Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,265
Positron emission tomography provides molecular imaging of biological processes
Phelps, M. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9226 · Cited by 1,229
Grafts of Fetal Dopamine Neurons Survive and Improve Motor Function in Parkinson's Disease
Lindvall, O., Brundin, P., Widner, H., Rehncrona, S., Gustavii, B., Frackowiak, R., Leenders, K. L., Sawle, G., Rothwell, J. C., Marsden, C. D., et al. (1990) · Science · doi:10.1126/science.2105529 · Cited by 1,207
Jouvet, M. (1972) · Neurophysiology and Neurochemistry of Sleep and Wakefulness · doi:10.1007/3-540-05462-6_2 · Cited by 1,098
TRANSPLANTATION OF EMBRYONIC DOPAMINE NEURONS FOR SEVERE PARKINSON'S DISEASE
Reed, R., Reene, P. A. E. G., Reeze, R. O. E. B., Ei, W., Ouchel, W. I. D. U. M., Ao, R. I. K., Infield, W., Ulver, S. H. C., Rojanowski, J. O. Q. T., Idelberg, D. A. E., et al. (2001) · Cited by 1,001
Martinez‐Martin, P., Rodriguez‐Blazquez, C., Kurtis, M. M., Chaudhuri, K. R., & on Behalf of the NMSS Validation Group (2011) · Movement Disorders · doi:10.1002/mds.23462 · Cited by 989
The human raphe nuclei and the serotonergic system
Hornung, J.-P. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.002 · Cited by 742
Freed, C. R., Breeze, R. E., Rosenberg, N. L., Schneck, S. A., Kriek, E., Qi, J.-X., Lone, T., Zhang, Y.-B., Snyder, J. A., Wells, T. H., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211263272202 · Cited by 739
Tryptophan depletion causes a rapid lowering of mood in normal males
Young, S. N., Smith, S. E., Pihl, R. O., & Ervin, F. R. (1985) · Psychopharmacology · doi:10.1007/bf00431803 · Cited by 713
Pathology of Parkinson’s disease: Changes other than the nigrostriatal pathway
Jellinger, K. A. (1991) · Molecular and Chemical Neuropathology · doi:10.1007/bf03159935 · Cited by 684
Chaudhuri, A., & Behan, P. O. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00411-1 · Cited by 651
Parkinson's disease symptoms: The patient's perspective
Politis, M., Wu, K., Molloy, S., G. Bain, P., Chaudhuri, K. R., & Piccini, P. (2010) · Movement Disorders · doi:10.1002/mds.23135 · Cited by 647
Self-citationDopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats
Carta, M., Carlsson, T., Kirik, D., & Bjorklund, A. (2007) · Brain · doi:10.1093/brain/awm082 · Cited by 636
Brooks, D. J., Ibanez, V., Sawle, G. V., Quinn, N., Lees, A. J., Mathias, C. J., Bannister, R., Marsden, C. D., & Frackowiak, R. S. J. (1990) · Annals of Neurology · doi:10.1002/ana.410280412 · Cited by 626
The parkinson's complex: Parkinsonism is just the tip of the iceberg
Langston, J. W. (2006) · Annals of Neurology · doi:10.1002/ana.20834 · Cited by 583
Lindvall, O. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520420033021 · Cited by 535
Greist, J. H. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950130053006 · Cited by 500
Widner, H., Tetrud, J., Rehncrona, S., Snow, B., Brundin, P., Gustavii, B., Björklund, A., Lindvall, O., & Langston, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211263272203 · Cited by 488
Depression in Parkinson??s Disease
STARKSTEIN, S. E., PREZIOSI, T. J., BOLDUC, P. L., & ROBINSON, R. G. (1990) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199001000-00005 · Cited by 477
Dyskinesias following neural transplantation in Parkinson's disease
Hagell, P., Piccini, P., Björklund, A., Brundin, P., Rehncrona, S., Widner, H., Crabb, L., Pavese, N., Oertel, W. H., Quinn, N., et al. (2002) · Nature Neuroscience · doi:10.1038/nn863 · Cited by 443
Clinical application of stem cell therapy in Parkinson's disease
Politis, M., & Lindvall, O. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-1 · Cited by 411
Self-citationPreferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
Kish, S. J., Tong, J., Hornykiewicz, O., Rajput, A., Chang, L.-J., Guttman, M., & Furukawa, Y. (2007) · Brain · doi:10.1093/brain/awm239 · Cited by 375
Wenning, G. K., Odin, P., Morrish, P., Rehncrona, S., Widner, H., Brundin, P., Rothwell, J. C., Brown, R., Gustavii, B., Hagell, P., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410420115 · Cited by 369
Lindvall, O., Widner, H., Rehncrona, S., Brundin, P., Odin, P., Gustavii, B., Frackowiak, R., Leenders, K. L., Sawle, G., Rothwell, J. C., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410310206 · Cited by 358
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 348
Altered serotonin metabolism in depressed patients with Parkinson's disease
Mayeux, R., Stern, Y., Cote, L., & Williams, J. B. W. (1984) · Neurology · doi:10.1212/wnl.34.5.642 · Cited by 343
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction
Pavese, N., Metta, V., Bose, S. K., Chaudhuri, K. R., & Brooks, D. J. (2010) · Brain · doi:10.1093/brain/awq268 · Cited by 333
Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson’s Patients with Neural Transplants
Politis, M., Wu, K., Loane, C., Quinn, N. P., Brooks, D. J., Rehncrona, S., Bjorklund, A., Lindvall, O., & Piccini, P. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000976 · Cited by 316
Self-citationBrundin, P. (2000) · Brain · doi:10.1093/brain/123.7.1380 · Cited by 305
Tanaka, H., Kannari, K., Maeda, T., Tomiyama, M., Suda, T., & Matsunaga, M. (1999) · NeuroReport · doi:10.1097/00001756-199902250-00034 · Cited by 302
Tremor in Parkinson’s disease and serotonergic dysfunction: An 11 C-WAY 100635 PET study
Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J., & Brooks, D. J. (2003) · Neurology · doi:10.1212/01.wnl.0000031424.51127.2b · Cited by 302
Williams, D. R., & Lees, A. J. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70146-0 · Cited by 300
Long-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease: Two Case Reports
Kefalopoulou, Z., Politis, M., Piccini, P., Mencacci, N., Bhatia, K., Jahanshahi, M., Widner, H., Rehncrona, S., Brundin, P., Björklund, A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4749 · Cited by 300
Self-citationPeschanski, M., Defer, G., N'Guyen, J. P., Ricolfi, F., Monfort, J. C., Remy, P., Geny, C., Samson, Y., Hantraye, P., Jeny, R., et al. (1994) · Brain · doi:10.1093/brain/117.3.487 · Cited by 280
Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease
Ballanger, B., Strafella, A. P., van Eimeren, T., Zurowski, M., Rusjan, P. M., Houle, S., & Fox, S. H. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.35 · Cited by 266
Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia
Rylander, D., Parent, M., O'Sullivan, S. S., Dovero, S., Lees, A. J., Bezard, E., Descarries, L., & Cenci, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.22097 · Cited by 262
Wilson, A. A., Ginovart, N., Schmidt, M., Meyer, J. H., Threlkeld, P. G., & Houle, S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000079i · Cited by 249
Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients
Politis, M., Wu, K., Loane, C., Brooks, D. J., Kiferle, L., Turkheimer, F. E., Bain, P., Molloy, S., & Piccini, P. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71640 · Cited by 244
Self-citationTransplantation of Human Fetal Dopamine Cells for Parkinson's Disease: Results at 1 Year
Freed, C. R. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530050021007 · Cited by 242
Occurrence and Localization of Catechol Amines in the Human Brain
Bertler, Å. (1961) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1961.tb02118.x · Cited by 242
Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study
Politis, M., Wu, K., Loane, C., Kiferle, L., Molloy, S., Brooks, D. J., & Piccini, P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.028 · Cited by 242
Self-citationCombined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
Munoz, A., Li, Q., Gardoni, F., Marcello, E., Qin, C., Carlsson, T., Kirik, D., Di Luca, M., Bjorklund, A., Bezard, E., et al. (2008) · Brain · doi:10.1093/brain/awn235 · Cited by 241
Bernheimer, H., Birkmayer, W., & Hornykiewicz, O. (1961) · Klinische Wochenschrift · doi:10.1007/bf01487648 · Cited by 240
Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18 F‐dopa PET study
Brooks, D. J., Playford, E. D., Ibanez, V., Sawle, G. V., Thompson, P. D., Findley, L. J., & Marsden, C. D. (1992) · Neurology · doi:10.1212/wnl.42.8.1554 · Cited by 232
Psychiatric comorbidities in patients with Parkinson disease and psychosis
Marsh, L., Williams, J. R., Rocco, M., Grill, S., Munro, C., & Dawson, T. M. (2004) · Neurology · doi:10.1212/01.wnl.0000129843.15756.a3 · Cited by 230
Clinical and biochemical features of depression in Parkinson's disease
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.6.756 · Cited by 226
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures
Politis, M., Wu, K., Loane, C., Turkheimer, F. E., Molloy, S., Brooks, D. J., & Piccini, P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181feb2ab · Cited by 224
Self-citationBuspirone: What is it all about?
Loane, C., & Politis, M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.032 · Cited by 222
Self-citationCannon, D. M., Ichise, M., Rollis, D., Klaver, J. M., Gandhi, S. K., Charney, D. S., Manji, H. K., & Drevets, W. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.016 · Cited by 219
Dyskinesia after fetal cell transplantation for parkinsonism: A PET study
Ma, Y., Feigin, A., Dhawan, V., Fukuda, M., Shi, Q., Greene, P., Breeze, R., Fahn, S., Freed, C., & Eidelberg, D. (2002) · Annals of Neurology · doi:10.1002/ana.10359 · Cited by 219
Perani, D., Garibotto, V., Gorini, A., Moresco, R. M., Henin, M., Panzacchi, A., Matarrese, M., Carpinelli, A., Bellodi, L., & Fazio, F. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.233 · Cited by 219
Pathophysiology and Treatment of Psychosis in Parkinson’s Disease: A Review
Zahodne, L. B., & Fernandez, H. H. (2008) · Drugs & Aging · doi:10.2165/00002512-200825080-00004 · Cited by 211
An Estimate of the Incidence of Depression in Idiopathic Parkinson's Disease
Dooneief, G., Mirabello, E., Bell, K., Marder, K., Stern, Y., & Mayeux, R. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530270125028 · Cited by 211
Khan, N. L., Valente, E. M., Bentivoglio, A. R., Wood, N. W., Albanese, A., Brooks, D. J., & Piccini, P. (2002) · Annals of Neurology · doi:10.1002/ana.10417 · Cited by 199
Cannon, D. M., Ichise, M., Fromm, S. J., Nugent, A. C., Rollis, D., Gandhi, S. K., Klaver, J. M., Charney, D. S., Manji, H. K., & Drevets, W. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.005 · Cited by 197
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: A PET study
Pavese, N., Evans, A. H., Tai, Y. F., Hotton, G., Brooks, D. J., Lees, A. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000242888.30755.5d · Cited by 191
Brain serotonin transporter binding in non‐depressed patients with Parkinson's disease
Guttman, M., Boileau, I., Warsh, J., Saint‐Cyr, J. A., Ginovart, N., McCluskey, T., Houle, S., Wilson, A., Mundo, E., Rusjan, P., et al. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01727.x · Cited by 187
Navailles, S., Bioulac, B., Gross, C., & De Deurwaerdère, P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.01.012 · Cited by 187
Graft‐induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio
Politis, M., Oertel, W. H., Wu, K., Quinn, N. P., Pogarell, O., Brooks, D. J., Bjorklund, A., Lindvall, O., & Piccini, P. (2011) · Movement Disorders · doi:10.1002/mds.23743 · Cited by 175
Self-citationWeight Change and Body Composition in Patients With Parkinson's Disease
BEYER, P. L., PALARINO, M. Y., MICHALEK, D., BUSENBARK, K., & KOLLER, W. C. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00269-3 · Cited by 173
Boileau, I., Warsh, J. J., Guttman, M., Saint‐Cyr, J. A., McCluskey, T., Rusjan, P., Houle, S., Wilson, A. A., Meyer, J. H., & Kish, S. J. (2008) · Movement Disorders · doi:10.1002/mds.22212 · Cited by 171
Hallucinations and sleep disorders in PD: Six-year prospective longitudinal study
Goetz, C. G., Wuu, J., Curgian, L. M., & Leurgans, S. (2005) · Neurology · doi:10.1212/01.wnl.0000148479.10865.fe · Cited by 171
Szabo, Z., Kao, P. F., Scheffel, U., Suehiro, M., Mathews, W. B., Ravert, H. T., Musachio, J. L., Marenco, S., Kim, S. E., Ricaurte, G. A., et al. (1995) · Synapse · doi:10.1002/syn.890200107 · Cited by 170
[ 123 I]β-CIT and SPECT in essential tremor and Parkinson's disease
Asenbaum, S., Pirker, W., Angelberger, P., Bencsits, G., Pruckmayer, M., & Brücke, T. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050124 · Cited by 167
Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease
Ballanger, B., Klinger, H., Eche, J., Lerond, J., Vallet, A., Bars, D. L., Tremblay, L., Sgambato, V., Broussolle, E., & Thobois, S. (2011) · Movement Disorders · doi:10.1002/mds.23895 · Cited by 163
Positron Emission Tomography of Striatal Serotonin Transporters in Parkinson Disease
Kerényi, L., Ricaurte, G. A., Schretlen, D. J., McCann, U. D., Varga, J., Mathews, W. B., Ravert, H. T., Dannals, R. F., Hilton, J., Wong, D. F., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.9.1223 · Cited by 154
MARSDEN, C. D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92797-0 · Cited by 150
Nicholson, S. L., & Brotchie, J. M. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.9.s3.1.x · Cited by 146
Frankle, W. G., Huang, Y. H., Hwang, D. R., Talbot, P. S., Slifstein, M., Heertum, R. V., Abi‐Dargham, A., & Laruelle, M. A. (2004) · PubMed · Cited by 146
Jaunarajs, K. L. E., Gupta, V., Alam, S., Park, J. Y., & Bishop, C. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.05.002 · Cited by 144
Predictors of weight loss in Parkinson's disease
Uc, E. Y., Struck, L. K., Rodnitzky, R. L., Zimmerman, B. M., Dobson, J., & Evans, W. J. (2006) · Movement Disorders · doi:10.1002/mds.20837 · Cited by 140
Diet, body size and micronutrient status in Parkinson's disease.
Abbott, R. A., Cox, M., Markus, H. S., & Tomkins, A. M. (1992) · PubMed · Cited by 139
Henderson, B. T. H., Clough, C. G., Hughes, R. C., Hitchcock, E. R., & Kenny, B. G. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530200062020 · Cited by 139
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa‐induced dyskinesia
Bézard, E., Tronci, E., Pioli, E. Y., Li, Q., Porras, G., Björklund, A., & Carta, M. (2013) · Movement Disorders · doi:10.1002/mds.25366 · Cited by 136
Szabó, Z. R., McCann, U. D., Wilson, A. A., Scheffel, U., Owonikoko, T. K., Mathews, W. B., Ravert, H. T., Hilton, J., Dannals, R. F., & Ricaurte, G. A. (2002) · PubMed · Cited by 134
Kannari, K., Yamato, H., Shen, H., Tomiyama, M., Suda, T., & Matsunaga, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00184.x · Cited by 133
Politis, M., Wu, K., Loane, C., Quinn, N. P., Brooks, D. J., Oertel, W. H., Björklund, A., Lindvall, O., & Piccini, P. P. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003391 · Cited by 133
Self-citationSpared Caudal Brainstem SERT Binding in Early Parkinson's Disease
Albin, R. L., Koeppe, R. A., Bohnen, N. I., Wernette, K., Kilbourn, M., & Frey, K. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600599 · Cited by 132
Depression and parkinson's disease: possible role of serotonergic mechanisms
Kostić, V., Djuričič, B., Čovičković-Šternić, N., Bumbaširević, L., Nikolić, M., & Mršulja, B. B. (1987) · Journal of Neurology · doi:10.1007/bf00314109 · Cited by 131
Maeda, T., Nagata, K., Yoshida, Y., & Kannari, K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.019 · Cited by 126
Towards an understanding of fatigue in Parkinson disease
Hagell, P., & Brundin, L. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.159772 · Cited by 123
Politis, M., Piccini, P. P., Pavese, N., Koh, S., & Brooks, D. J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.07.021 · Cited by 122
Self-citationSerotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD
Loane, C., Wu, K., Bain, P. G., Brooks, D. J., Piccini, P. P., & Politis, M. (2013) · Neurology · doi:10.1212/wnl.0b013e318292a31d · Cited by 122
Self-citationAcute Tryptophan Depletion. Part II: Clinical Effects and Implications
Bell, C., Hood, S. D., & Nutt, D. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01628.x · Cited by 111
Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability
Politis, M., & Loane, C. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/172893 · Cited by 109
Self-citationFénelon, G. (2008) · CNS Spectrums · doi:10.1017/s1092852900017284 · Cited by 109
Navailles, S., Benazzouz, A., Bioulac, B. H., Gross, C. E., & Deurwaerdère, P. D. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5031-09.2010 · Cited by 108
Positron emission tomography imaging in neurological disorders
Politis, M., & Piccini, P. P. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6428-3 · Cited by 107
Self-citation[11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with pet
Suehiro, M., Scheffel, U., Ravert, H. T., Dannals, R. F., & Wagner, H. N. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90440-e · Cited by 104
Obsessive-compulsive symptoms in Parkinson's disease
Alegret, M. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.3.394 · Cited by 104
Serotonin innervation of basal ganglia in monkeys and humans
Parent, M., Wallman, M., Gagnon, D., & Parent, A. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.04.005 · Cited by 100
Parkinson’s disease psychosis 2010: A review article
Friedman, J. H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.05.004 · Cited by 99
REGIONAL DISTRIBUTION OF MONOAMINES AND THEIR METABOLITES IN THE HUMAN BRAIN
Mackay, A. V. P., Yates, C. M., Wright, A., Hamilton, P., & Davies, P. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb10792.x · Cited by 98
Olanow, C. W., Graciès, J., Goetz, C. G., Stoessl, A. J., Freeman, T., Kordower, J. H., Godbold, J., & Obeso, J. A. (2008) · Movement Disorders · doi:10.1002/mds.22208 · Cited by 95
Muñoz, A., Carlsson, T., Tronci, E., Kirik, D., Björklund, A., & Carta, M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.033 · Cited by 94
Hipólide, D. C., Moreira, K. D. M., Barlow, K. B. L., Wilson, A. A., Nóbrega, J. N., & Tufik, S. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.015 · Cited by 89
Jaunarajs, K. L. E., Dupre, K. B., Ostock, C. Y., Button, T., Terrence Deak, B., & Bishop, C. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833e7e80 · Cited by 87
Matsumoto, R., Ichise, M., Ito, H., Ando, T., Takahashi, H., Ikoma, Y., Kosaka, J., Arakawa, R., Fujimura, Y., Ota, M., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.069 · Cited by 86
Dupre, K. B., Jaunarajs, K. L. E., Barnum, C. J., & Bishop, C. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.031 · Cited by 85
Lee, J., Jeon, B. S., Kim, H., & Park, S. S. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.08.009 · Cited by 85
Sleep Deprivation Increases Cerebral Serotonin 2A Receptor Binding in Humans
Elmenhorst, D., Kroll, T., Matusch, A., & Bauer, A. (2012) · SLEEP · doi:10.5665/sleep.2230 · Cited by 82
Quantitative Analysis of [ 11 C]AZ10419369 Binding to 5-HT 1B Receptors in Human Brain
Varnäs, K., Nyberg, S., Halldin, C., Varrone, A., Takano, A., Karlsson, P., Andersson, J. D., McCarthy, D. J., Smith, M., Pierson, M. E., et al. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.55 · Cited by 81
Depression in Parkinson's disease: impediments to recognition and treatment options.
Poewe, W. H., & Luginger, E. (1999) · PubMed · Cited by 81
Parkinson's disease and weight loss: A study with anthropometric and nutritional assessment
Durrieu, G., Llau, M. E., Rascol, O., Sénard, J., Rascol, A., & Montastruc, J. (1992) · Clinical Autonomic Research · doi:10.1007/bf01818955 · Cited by 78
Serotonin innervation of human basal ganglia
Wallman, M., Gagnon, D., & Parent, M. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07621.x · Cited by 78
Positron emission tomography neuroimaging in Parkinson's disease.
Loane, C., & Politis, M. (2011) · PubMed · Cited by 75
Self-citationLevodopa therapy in Parkinson's disease.
Koller, W. C., & Hubble, J. P. (1990) · PubMed · Cited by 74
Tohgi, H., Abe, T., Takahashi, S., Takahashi, J., & Hamato, H. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90111-w · Cited by 72
Wilson, A. A., & Houle, S. (1999) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/(sici)1099-1344(19991230)42:13<1277::aid-jlcr284>3.0.co;2-q · Cited by 71
Hesse, S., Stengler, K., Regenthal, R., Patt, M., Becker, G., Franke, A., Knüpfer, H., Meyer, P., Luthardt, J., Jahn, I., et al. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001604 · Cited by 67
Borah, A., & Mohanakumar, K. P. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9213-6 · Cited by 65
Sharp, S. I., Ballard, C. G., Ziabreva, I., Piggott, M. A., Perry, R. H., Perry, E. K., Aarsland, D., Ehrt, U., Larsen, J. O., & Francis, P. T. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000161058 · Cited by 56
Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?
Politis, M. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-80 · Cited by 56
Self-citationDupre, K. B., Jaunarajs, K. L. E., Steiniger, A., Klioueva, A., Negron, G. E., Lormand, L., Park, J. Y., & Bishop, C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1135-6 · Cited by 55
Sjödin, A. M., Gasteyger, C., Nielsen, A.-L. H., Raben, A., Mikkelsen, J. D., Jensen, J. K., Meier, D., & Astrup, A. V. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.87 · Cited by 50
Pharmacotherapy for obsessive-compulsive disorder.
Greist, J. H., & Jefferson, J. W. (1998) · PubMed · Cited by 49
Mignon, L., & Wolf, W. A. (2005) · Neuroreport · doi:10.1097/00001756-200505120-00009 · Cited by 48
Lees, A. J., Shaw, K. M., & Stern, G. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92939-7 · Cited by 47
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
Bézard, E., Muñoz, A., Tronci, E., Pioli, E. Y., Li, Q., Porras, G., Björklund, A., & Carta, M. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.10.002 · Cited by 47
Kuhn, D. M., & Arthur, R. E. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00238-7 · Cited by 45
Serotonergic mediated body mass index changes in Parkinson's disease
Politis, M., Loane, C., Wu, K., Brooks, D. J., & Piccini, P. P. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.009 · Cited by 45
Self-citationHammoud, D. A., Endres, C. J., Hammond, E. R., Uzuner, Ö., Brown, A. M., Nath, A., Kaplin, A. I., & Pomper, M. G. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.10.037 · Cited by 45
Nefazodone and REM sleep: how do antidepressant drugs decrease REM sleep?
Vogel, G., Cohen, J., Mullis, D., Kensler, T., & Kaplita, S. (1998) · Sleep · doi:10.1093/sleep/21.1.70 · Cited by 44
Hashiguti, H., Nakahara, D., Maruyama, W., Naoi, M., & Ikeda, T. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244998 · Cited by 43
Psychosis in Parkinson’s disease: ‘between a rock and a hard place’
Henderson, M. J., & Mellers, J. D. C. (2000) · International Review of Psychiatry · doi:10.1080/09540260020002541 · Cited by 43
Shin, E., García, J., Winkler, C., Björklund, A., & Carta, M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.038 · Cited by 42
Lelieveld, I. M., Müller, M. L. T. M., Bohnen, N. I., Koeppe, R. A., Chervin, R. D., Frey, K. A., & Albin, R. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040166 · Cited by 38
Lane, E. L., Brundin, P., & Cenci, M. A. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.014 · Cited by 37
Hummerich, R., Reischl, G., Ehrlichmann, W., Machulla, H., Heinz, A., & Schloss, P. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02585.x · Cited by 36
Recent advances in depression research: from stress to molecular biology and brain imaging.
Risch, S. C. (1997) · PubMed · Cited by 25
Test Retest Reproducibility of 18F-MPPF PET in Healthy Humans: A Reliability Study
Costes, N., Zimmer, L., Reilhac, A., et al. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.041905 · Cited by 24
Gil, S. J., Park, C. H., Lee, J. E., Minn, Y. K., & Koh, H. C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.12.006 · Cited by 23
Brain imaging after neural transplantation
Politis, M., & Piccini, P. P. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84010-5 · Cited by 19
Self-citationSleep disorders in Parkinson’s disease
Zesiewicz, T. A. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4578 · Cited by 19
In vivo imaging of the integration and function of nigral grafts in clinical trials
Politis, M., & Piccini, P. P. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59575-1.00009-0 · Cited by 17
Self-citationPolitis, M. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-50 · Cited by 15
Self-citationPharmacotherapy of Obsessive Compulsive Disorder
Sasson, Y., Lustig, M., Iancu, I., Chopra, M., Hendler, T., & Zohar, J. (1997) · KARGER eBooks · doi:10.1159/000061358 · Cited by 14
Gonzalez-Salvador (1999) · doi:10.1002/(sici)1099-1166(199909)14:9
Cited by
Circuit Mechanisms of Parkinson’s Disease
McGregor, M. M., & Nelson, A. B. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.004 · Cited by 624
Fatigue in Parkinson's disease: A systematic review and meta‐analysis
Siciliano, M., Trojano, L., Santangelo, G., De Micco, R., Tedeschi, G., & Tessitore, A. (2018) · Movement Disorders · doi:10.1002/mds.27461 · Cited by 291
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Galts, C. P. C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil-Mohapel, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.002 · Cited by 269
Molecular and anatomical organization of the dorsal raphe nucleus
Huang, K. W., Ochandarena, N. E., Philson, A. C., Hyun, M., Birnbaum, J. E., Cicconet, M., & Sabatini, B. L. (2019) · eLife · doi:10.7554/elife.46464 · Cited by 267
Blesa, J., Trigo-Damas, I., Dileone, M., del Rey, N. L.-G., Hernandez, L. F., & Obeso, J. A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.002 · Cited by 256
Metadata
- Authors
- Politis, M., & Niccolini, F.
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 277
- Pages
- 136-145
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W2028911868
- Cited by
- 306
- References
- 143
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.